This article is educational and reflects guidance available on July 15, 2026. A cat with facial swelling, repeated vomiting, widespread hives, collapse, pale or blue gums, or breathing difficulty after vaccination needs emergency veterinary care. A persistent or enlarging injection-site mass needs prompt examination.

FeLV Vaccine for Cats: Schedule, Safety, Effectiveness, and Risk

Quick Answer

The FeLV vaccine for cats reduces the risk of persistent infection and disease caused by feline leukemia virus. It is an important layer of prevention, but it is not 100% effective, does not treat an infected cat, and does not replace testing or preventing contact with potentially infected cats [1][2].

Current US AAHA/AAFP guidance treats FeLV vaccination as core for kittens and young cats under one year because younger cats are more biologically susceptible and their future lifestyle can change. For low-risk adults with no plausible contact with FeLV-positive cats or cats of unknown status, it is non-core and based on individual risk [1]. The 2024 WSAVA guidance similarly considers FeLV core for young cats under one year where FeLV is prevalent and for older cats with continuing exposure risk [3]. “Core” here is conditional on age and regional epidemiology, not a law that every cat everywhere receives every product forever.

The typical primary series begins as early as eight weeks of age and uses two doses three to four weeks apart, whether the cat starts before or after 16 weeks. A booster is given one year after the last primary dose. Cats at continuing high risk are generally revaccinated annually; lower-risk adult intervals can differ by product label, vaccine type, jurisdiction and guideline [1][3]. A veterinarian must check the exact licensed product rather than applying one internet schedule.

Cats should be tested for FeLV infection before vaccination, especially when status is unknown, after possible exposure, when newly acquired, and when ill [1][2][3]. Most point-of-care FeLV screening assays detect circulating p27 antigen. FeLV vaccination does not ordinarily cause a positive p27 antigen test and does not create FeLV proviral DNA. A positive screening result has major consequences and should usually be confirmed or clarified with additional testing, particularly in a healthy low-risk cat [2].

Common vaccine reactions are short-lived soreness, lethargy, reduced appetite or mild fever. Severe allergic reactions are uncommon but urgent. Feline injection-site sarcoma (FISS) is rare and has been associated with injections and chronic inflammation, not exclusively FeLV vaccines. Record the product and site and monitor any lump using the “3-2-1” trigger: investigate a mass that persists for three months, is larger than two centimeters, or enlarges one month after injection [1][4]. Do not avoid a clearly indicated vaccine solely because a rare adverse event exists; make an individualized benefit-risk decision.

What Is Feline Leukemia Virus?

Feline leukemia virus is a gammaretrovirus that infects domestic cats and related felids. It can impair immunity, damage bone marrow, cause anemia, contribute to lymphoma and leukemia, and create varied inflammatory or neurologic disease. Clinical outcome depends on age, dose, route, immune response and whether infection becomes progressive, regressive, abortive or focal [2].

The name is confusing. FeLV can cause leukemia, but many infected cats never develop leukemia. It is a virus, not a cancer vaccine target in the ordinary sense.

How FeLV spreads

FeLV spreads mainly through close cat-to-cat contact involving saliva and other secretions. Mutual grooming, shared close living, bite wounds, prolonged contact, queen-to-kitten transmission and, less efficiently, shared food or litter resources can play roles. The virus survives poorly in the environment and is readily inactivated by routine cleaning [2].

Risk is higher for cats that:

• go outdoors unsupervised;
• fight or sustain bite wounds;
• live with a FeLV-positive cat;
• join a household or group without testing;
• live in a changing multi-cat population;
• have an unknown history; or
• are kittens exposed through their mother or companions.

A screened, stable indoor-only adult household has lower risk, not zero risk. Escapes, new cats, foster animals and future moves can change it. Risk should be reviewed at every wellness visit rather than assigned for life.

FeLV is not FIV or FIP

FeLV and feline immunodeficiency virus (FIV) are different retroviruses with different tests, transmission patterns and vaccine availability. FIP is a systemic disease associated with feline coronavirus, not FeLV. The FIP guide explains why coronavirus antibody or fecal PCR does not diagnose FIP.

An “all-in-one” cat test often screens for FeLV antigen and FIV antibody, but the two result lines mean different things. Vaccination against FeLV does not vaccinate against FIV or FIP.

Who Should Get the FeLV Vaccine?

Kittens and young cats

AAHA/AAFP recommends FeLV vaccination for kittens and young cats under one year because age-related susceptibility is higher and future exposure is hard to predict [1]. A kitten adopted as indoor-only may escape, enter a multi-cat home, travel, foster with other cats or encounter an infected cat later.

Testing before the series helps establish baseline status. Vaccinating an already infected kitten does not clear infection and can create false assumptions about protection. A negative early test does not always exclude very recent infection; retesting after the relevant exposure window may be needed [2].

Outdoor cats

Cats with unsupervised outdoor access or likely contact with unknown-status cats are candidates for ongoing vaccination [1][3]. Vaccination does not make roaming safe. Traffic, trauma, parasites, toxins, predation, fights and other infections remain. Controlled outdoor access, a secure catio or harness activity lowers multiple risks.

Cats living with a FeLV-positive cat

The safest infection-prevention approach is separate housing that prevents close contact. When owners elect mixed-status cohabitation, every negative cat should be tested, vaccinated and managed with a veterinarian, with recognition that protection is incomplete [2].

Do not vaccinate the positive cat in an attempt to reduce shedding or cure infection. FeLV-positive cats still need individualized core vaccination and preventive care based on health and exposure, but FeLV vaccine has no therapeutic benefit for established infection.

Multi-cat homes, foster homes and catteries

Risk depends on stability, screening and contact. A closed household of repeatedly negative indoor adults differs from a foster home admitting unknown cats. New cats should be tested before introduction and separated during assessment. Vaccination is an adjunct, not a replacement for intake quarantine and testing.

The new-pet quarantine guide explains how a temporary separation period supports testing, observation and a safer introduction without treating quarantine as a substitute for veterinary care.

Shelter protocols differ because time, turnover, disease prevalence and length of stay matter. A single shelter dose should not be represented as a complete two-dose FeLV primary series.

Indoor-only adult cats

A strictly indoor adult living only with tested negative cats may have little ongoing benefit after the young-cat series. AAHA/AAFP calls FeLV vaccine non-core for low-risk adults with no potential exposure to positive or unknown-status cats [1]. The veterinarian reviews future plans, household stability, escapes, foster activity and local prevalence.

“Indoor” is not a biological category. A screened apartment cat that never meets another cat is different from an indoor cat sharing a home with an outdoor housemate. The decision should be documented and revisited.

FeLV-positive cats

FeLV vaccination is not indicated to treat existing infection. Confirm status before making irreversible housing or end-of-life decisions. The 2020 retrovirus guidelines emphasize that regressive infection, recent exposure, atypical results and changing immune response complicate a one-time test [2].

A positive result is not an automatic euthanasia recommendation. Many infected cats can have meaningful quality time with appropriate indoor care, monitoring and prompt treatment of illness.

Pregnant, ill or immunocompromised cats

Vaccination decisions depend on immediate exposure risk, product type, illness severity, reproductive status and label. Elective vaccination is often postponed during significant acute illness. Modified-live components in combination products raise different reproductive concerns than an FeLV-only product. Do not generalize from the FeLV antigen alone; the exact vaccine matters.

FeLV Vaccine Schedule

Primary kitten series

The standard schedule is:

1. First dose at eight weeks of age or later.
2. Second dose three to four weeks later.
3. Revaccination one year after the last primary-series dose.
4. Future boosters based on ongoing risk and the product license [1][3].

Unlike the repeated FVRCP kitten sequence, FeLV generally uses two primary doses rather than dosing every three to four weeks until 16 to 20 weeks. Owners often confuse schedules when vaccines are given at the same visits.

Cats older than 16 weeks starting for the first time

They also receive two doses three to four weeks apart, followed by a booster one year after the second dose if vaccination remains indicated [1][3]. One dose does not complete the labeled primary series for a previously unvaccinated adult.

High-risk adult boosters

AAHA/AAFP guidance recommends annual revaccination for cats with regular exposure to FeLV-positive or unknown-status cats, especially fighting or outdoor risk. WSAVA 2024 likewise recommends annual boosters for continuing high risk [1][3].

Lower-risk adult boosters

For inactivated products, AAHA/AAFP discusses two-to-three-year intervals where product licensure allows for adults with only periodic exposure; it describes two years as a consensus interval in mature cats with periodic risk. Recombinant product guidance in the same US table recommends annual revaccination while risk persists [1]. WSAVA tells clinicians to follow the product leaflet for lower-risk intervals, such as every two or three years [3].

This is not contradiction so much as product- and risk-specific guidance. Use the product actually available and licensed in the country. “All FeLV vaccines last exactly three years” is wrong.

If a booster is late

The correct response depends on product labeling, time elapsed, prior completion and risk. Do not assume the entire lifetime series always restarts, and do not assume one late dose restores full protection immediately. The veterinarian may consult the manufacturer and current guidelines.

Keep certificates with product, lot, date, site and route. Records help after travel, boarding, adverse reaction or a change in clinic.

Why Testing Comes Before Vaccination

The 2020 AAFP retrovirus guidelines recommend testing cats as soon as possible after acquisition, after exposure to an infected or unknown-status cat, before FeLV vaccination, and whenever illness occurs [2]. The goal is not to “qualify” a cat morally; it is to avoid unnecessary vaccination and establish status for management.

Screening antigen tests

Most in-clinic tests detect soluble FeLV p27 antigen in blood. A positive result supports circulating viral antigen and may indicate progressive infection, but transient antigenemia, technical error and discordant infection states occur. A healthy low-risk cat with an unexpected result needs additional testing, often with repeat antigen, laboratory methods and/or proviral PCR chosen for timing and context [2].

PCR

Proviral DNA PCR detects integrated viral genetic material. It can help characterize discordant or regressive infection, but assay quality and interpretation matter. A negative PCR does not fix a poorly timed test after very recent exposure, and a positive result does not by itself describe current shedding or clinical prognosis.

Retesting after exposure

Testing immediately after a bite establishes a baseline but may be too early to detect new infection. The veterinarian schedules repeat testing based on route, timing and assay. Keep exposed cats separated during the uncertainty window.

Does vaccination make a FeLV test positive?

No for the routinely used p27 antigen test. FeLV vaccines do not contain a replicating virus that creates progressive infection, and they should not create proviral DNA. Antibody tests are not the routine method for diagnosing FeLV infection, and vaccine-induced immune responses can complicate research antibody assays.

This differs from FIV: historical FIV vaccination could complicate some FIV antibody testing. Do not transfer that rule to FeLV antigen screening.

How Effective Is the FeLV Vaccine?

FeLV vaccines reduce persistent antigenemia and related disease, but no vaccine prevents every infection or every marker under every challenge. Efficacy estimates differ because studies use different virus strains, doses, exposure routes, endpoints, intervals and products.

A 2017 controlled comparison gave two doses 21 days apart to 20 cats per group, then challenged them with a heterologous FeLV isolate. Persistent antigenemia developed in 75% of placebo cats, compared with 15%, 5% and 5% in the three vaccine groups; adjusted comparisons among vaccines were not statistically significant [5]. This supports meaningful protection while showing that vaccinated cats were not universally protected.

A 2014 study of 50 kittens using a different high-virulence model reported very different relative performance between an inactivated and recombinant product [6]. Both studies were manufacturer-associated and laboratory challenges, and their conflicting rankings are one reason AAHA/AAFP states that evidence comparing recombinant and inactivated FeLV vaccines is conflicting [1]. Do not choose a product from one headline percentage.

An older “natural challenge” study housed vaccinated kittens with persistently infected cats for 31 weeks. Persistent blood positivity occurred in 7 of 11 controls and varied across vaccine groups; bone-marrow virus was detected in some vaccinated cats even when persistent blood antigenemia was prevented [7]. Modern infection categories and tests have evolved, but the study illustrates that preventing persistent antigenemia and achieving sterilizing immunity are not identical.

What vaccination is intended to prevent

The practical target is progressive infection and FeLV-associated disease. Some vaccinated cats may show limited or transient viral markers after challenge while avoiding persistent viremia. Claims should specify the endpoint.

Why exposure prevention still matters

Vaccine protection can be overwhelmed, incomplete or poorly matched to a cat that failed to respond. Avoiding contact with infected saliva and bite wounds reduces challenge dose and protects against diseases the vaccine does not cover. Testing new cats and keeping infected cats separate remains the strongest prevention strategy [2][3].

Types of FeLV Vaccine

Available products vary by country and year. Broad categories include:

• inactivated whole-virus or subunit vaccines, often adjuvanted;
• recombinant canarypox-vectored products, which may be nonadjuvanted or formulated differently by market; and
• combination products containing FeLV with other antigens.

“Nonadjuvanted” does not mean risk-free, and “killed” does not mean ineffective. Comparative challenge studies conflict [1][5][6]. The clinician weighs label, duration of immunity, route, availability, injection-site strategy, prior reaction and exposure.

Do not split a feline vaccine dose based on body size. A small cat does not receive half an immunizing dose unless the product specifically provides such instructions. Do not mix products in one syringe or substitute an oral product.

FeLV Vaccine Side Effects

Expected mild reactions

For a day or two, some cats have:

• sleepiness;
• reduced appetite;
• tenderness at the site;
• mild fever;
• reluctance to jump; or
• a small temporary lump.

Provide quiet access to food, water, litter and comfortable temperature. Do not give acetaminophen, ibuprofen, aspirin, antihistamines or leftover medication unless the veterinarian directs it. Acetaminophen is especially dangerous to cats.

Call the clinic if signs are marked, persist beyond the timeframe given, worsen, or include repeated vomiting, significant pain or failure to eat.

Allergic reactions

Facial swelling, hives, repeated vomiting, diarrhea, weakness, collapse or breathing difficulty can indicate an acute hypersensitivity reaction. Seek emergency care. Reactions may develop rapidly, so follow the clinic's observation instructions.

The emergency-vet guide explains why breathing difficulty, collapse, marked facial swelling or repeated vomiting should not be watched at home while an owner contacts the nearest clinic.

A prior reaction does not automatically mean all future vaccines are impossible. The veterinarian verifies which product and antigens were administered, separates vaccines when useful, changes product or route, assesses current exposure risk, and plans observation. Owners should not premedicate independently because it can cause harm or mask early signs.

Feline injection-site sarcoma

FISS is an uncommon, locally aggressive tumor arising at a prior injection site. Vaccines, long-acting drugs and other injections have been associated; chronic inflammation in a genetically susceptible cat is a leading hypothesis [4]. Calling every case a “vaccine sarcoma” oversimplifies the evidence.

A UK incidence study estimated roughly one FISS per 5,000 to 12,500 vaccination visits, depending on denominator, using 14 cases in a convenience sample of practices [8]. Other estimates vary. The event is rare, while FeLV infection can be devastating in exposed young cats.

The ABCD guideline notes lower reported risk with modified-live and recombinant vaccines than adjuvanted products, but no injected product is risk-free [4]. Product selection is one part of risk reduction; avoiding unnecessary injections and documenting location matter too.

The 3-2-1 rule

Have an injection-site mass evaluated and consider biopsy when it:

• remains for three months after injection;
• is larger than two centimeters; or
• is still enlarging one month after injection.

These are investigation triggers, not reassurance to ignore a rapidly growing or painful lump until a deadline. Contact the veterinarian earlier when concerned. Fine-needle aspiration may not distinguish reactive inflammation from sarcoma; an appropriately planned incisional biopsy can be needed. Poorly planned excision can compromise definitive surgery.

Injection Site and Documentation

AAHA/AAFP supports administering different feline vaccines at standardized distal-limb sites so a persistent mass can be linked to a product and, if cancer develops, treated with wider surgical options. Their resource supports FeLV below the left stifle, with other vaccines assigned elsewhere [9]. Local guidance can differ, and some clinicians use the tail for selected vaccines based on training and feasibility.

The record should include:

• manufacturer and product name;
• antigen components;
• lot and expiration;
• dose and route;
• exact anatomical site;
• date;
• administering clinician; and
• immediate reaction.

“Left rear” is less useful than a precise distal site. Owners can photograph the location on a body diagram.

Do not massage a new lump aggressively or apply unprescribed creams. Measure gently with a ruler and record change.

Indoor Cat Decision-Making

Ask four questions:

1. Is the cat under one year?
2. Could it contact a FeLV-positive or unknown-status cat?
3. Could the lifestyle change before the next review?
4. What product and interval fit local guidance?

A kitten receives the young-cat series even when currently indoors under US guidance, because susceptibility and future uncertainty are high [1]. A mature indoor-only cat in a closed, tested-negative home may discontinue boosters after individualized discussion. An indoor cat living with an outdoor cat has ongoing exposure potential.

Balanced decision-making considers both infection consequences and injection burden. “Indoor means never” and “every cat annually forever” are both too blunt.

Multi-Cat Households

Bringing home a new cat

Keep the new cat separate until examination and retrovirus testing. Test existing cats if their status or exposure warrants it. Exchange scent and introduce behaviorally only after medical risk is addressed.

A negative intake test may need repetition if exposure was recent. Vaccination does not become fully effective immediately, and the primary series takes two doses. Do not allow contact the day of the first injection under the assumption that protection is complete.

Living with a FeLV-positive cat

Separate housing provides the best protection. If cats remain together, minimize fighting, share the decision with the veterinarian, vaccinate confirmed-negative housemates and retest as advised. Separate bowls and litter boxes alone cannot remove saliva exposure from grooming and close contact.

The positive cat should live indoors, receive complete nutrition, parasite control, regular examination and prompt workup of illness. Avoid raw diets because immunocompromise and pathogen exposure can combine.

Foster and rescue settings

Create distinct intake, isolation and resident zones. Clean routinely, control fomite movement and do not mix unknown-status cats solely because they look healthy. FeLV is fragile outside the host, so close contact is a larger concern than elaborate environmental decontamination [2].

Myths and Misunderstandings

“The FeLV vaccine causes feline leukemia”

Licensed vaccines do not produce progressive FeLV infection. A cat may have been infected before vaccination or during the immune-development window, or vaccination may fail. Baseline testing helps distinguish timing.

“A vaccinated cat never needs testing”

False. The vaccine is not perfect. Test after compatible exposure or illness and when status is needed for introduction or blood donation [2].

“A positive FeLV screening test is a death sentence”

False. Confirm or clarify unexpected results. Infection outcomes vary, and positive cats can have meaningful quality of life. Do not euthanize solely from one unconfirmed point-of-care result.

“FeLV vaccine makes the antigen test positive”

False for routine p27 screening. Vaccination does not create circulating FeLV p27 antigen or integrated proviral DNA.

“Indoor cats have zero risk”

Risk can be very low but changes with escape, new animals, an outdoor housemate, fostering, travel or relocation. Review rather than assume.

“Titers can replace FeLV boosters”

There is no validated routine FeLV antibody titer threshold that reliably substitutes for label-based revaccination. Protection includes cellular immunity and depends on product and exposure. Do not use a commercial titer as an automatic exemption.

“Nonadjuvanted means no sarcoma risk”

No injection is risk-free. Inflammation and individual susceptibility are complex [4]. Use indicated vaccines thoughtfully and document sites.

“One shot protects an adult cat”

A previously unvaccinated cat needs two primary doses three to four weeks apart under current guidelines and labels [1][3].

“Half a dose is safer for a small cat”

Vaccine dose is formulated per cat, not per kilogram. Partial dosing can compromise protection and is not a safe reaction strategy.

Preparing for the Vaccine Visit

Bring:

• prior vaccine records and dates;
• FeLV/FIV test results;
• history of outdoor access, fighting or new cats;
• prior vaccine or medication reactions;
• current illness, medication and pregnancy information; and
• travel or boarding plans.

Ask:

1. Is my cat's FeLV status documented, and is testing needed today?
2. Is FeLV vaccination core or risk-based for this age and region?
3. Which product and route are being used?
4. When is dose two due?
5. When is the one-year booster due?
6. What future interval fits this cat's risk and the label?
7. Where will the vaccine be administered and recorded?
8. What reactions require a call or emergency visit?
9. How should I monitor an injection-site lump?
10. How will the plan change if the cat becomes indoor-only or gains a new housemate?

Use a carrier that opens from the top or separates, familiar bedding and low-stress handling. Feline-friendly care can reduce restraint and stress. Do not withhold food unless instructed; treats can help handling.

Aftercare

Keep the cat indoors and observe for at least the period specified by the clinic. Offer normal water, litter and a comfortable hiding place. Mild sleepiness can occur, but the cat should remain responsive and able to breathe comfortably.

Do not press repeatedly on the site. Note appetite, vomiting, facial swelling, breathing, gait and alertness. For a lump, record its location, approximate size and change.

If several vaccines were administered, the detailed record helps future planning. A reaction does not identify the responsible antigen from timing alone.

Vaccine Versus Exposure Control

The safest prevention plan uses layers:

• test cats before introduction;
• keep known-positive and negative cats separated;
• vaccinate young and at-risk negative cats;
• prevent unsupervised outdoor contact and fighting;
• neuter or spay when appropriate to reduce roaming-related exposures, without treating surgery as complete prevention;
• use individual bowls, litter resources and stable groups; and
• retest after exposure or compatible illness.

Vaccination is valuable precisely because perfect exposure control sometimes fails. Exposure control remains valuable because vaccination is incomplete.

How FeLV Vaccination Fits With Other Cat Vaccines

FeLV is separate from the core FVRCP antigens—feline panleukopenia, herpesvirus and calicivirus—and from rabies. Some commercial products combine components, which can obscure what was given. The core cat vaccines guide explains broader scheduling.

Do not assume every vaccine at a kitten visit has the same booster interval. The FVRCP series accounts for maternally derived antibody through 16 to 20 weeks, while FeLV uses a two-dose primary series and one-year booster [1]. Rabies timing follows label and law.

Separating vaccines between visits may help attribute a prior reaction or reduce simultaneous antigen load in a specific cat, but it also creates more trips and delays protection. There is no universal rule. The veterinarian balances urgency, stress and history.

FeLV Vaccine in Special Situations

Previous injection-site sarcoma

A cat with prior FISS needs oncology and primary-care coordination. Avoid unnecessary injections, choose routes and sites deliberately and assess exposure risk carefully. Do not make the decision from fear alone; recurrent infection risk and cancer treatment status both matter.

Previous allergic reaction

Confirm which products were given and whether the event was truly allergic. If exposure risk remains high, the veterinarian may choose another product, stage vaccines, observe longer or use a specialist plan. Owner-administered diphenhydramine is not a safe universal protocol.

Unknown vaccine history

Testing and a two-dose primary series are often used when records cannot be verified and vaccination is indicated. A verbal statement or collar tag is not a complete record. Do not order antibody titers as a routine shortcut; FeLV correlates of protection are not validated for that purpose.

Community cats

Decisions depend on return-to-field setting, local prevalence, feasibility of a second dose and likely contact. Sterilization, rabies and core viral vaccination often take priority in one-time programs. A single FeLV dose should not be advertised as a completed series. Program veterinarians set policy from population risk and resources.

Travel and relocation

FeLV prevalence, product licensing and guideline classification vary. A cat moving from a closed indoor home to a region with outdoor access may need testing and a new series before exposure. Start early enough for both doses and immune response.

Frequently Asked Questions

What is the FeLV vaccine for cats?

It reduces the risk of persistent feline leukemia virus infection and related disease. It does not treat existing infection and cannot prevent every infection.

Do kittens need the FeLV vaccine?

US AAHA/AAFP guidance considers it core for kittens and young cats under one year because they are more susceptible and future exposure can change [1]. Regional WSAVA guidance adds local prevalence and continuing risk [3].

What is the FeLV vaccine schedule?

Two doses three to four weeks apart beginning as early as eight weeks, followed by a booster one year after the last primary dose. Future intervals depend on exposure risk, product and local guidance [1][3].

Does an indoor cat need FeLV boosters?

A mature cat in a stable, tested-negative indoor household may not need ongoing boosters. A kitten still receives the young-cat series under US guidance. Indoor cats with outdoor housemates, foster contact or escape risk may remain candidates.

Should a cat be tested before FeLV vaccination?

Yes. Guidelines recommend establishing negative status before vaccination and testing after acquisition, exposure or illness [1][2][3]. A very recent exposure may require repeat testing.

Can the vaccine cause a positive FeLV test?

It should not make routine p27 antigen or proviral DNA tests positive. An unexpected positive result needs confirmation and context, not dismissal as vaccine interference.

Can a FeLV-positive cat be vaccinated against FeLV?

The vaccine does not treat or clear infection and provides no therapeutic FeLV benefit. Confirm status and create a preventive-care plan for the positive cat with a veterinarian.

How effective is the vaccine?

Controlled challenge studies show substantial reductions in persistent antigenemia, but results vary by product and model and some vaccinated cats still become infected [5][6][7]. No responsible estimate is 100%.

What are common side effects?

Short-lived lethargy, reduced appetite, mild fever, soreness or a small lump can occur. Facial swelling, repeated vomiting, collapse or breathing difficulty is an emergency.

What is the 3-2-1 rule?

Investigate an injection-site mass that persists three months, is larger than two centimeters or enlarges one month after injection. Contact the veterinarian sooner for rapid growth, pain or concern.

Is the recombinant vaccine safer than an inactivated vaccine?

Some evidence suggests nonadjuvanted or recombinant products cause less inflammation, but no product is risk-free and comparative efficacy studies conflict [1][4][5][6]. Product choice is individualized.

Can FeLV titers replace boosters?

No validated routine antibody threshold reliably substitutes for recommended FeLV revaccination. Follow risk assessment, label and current guidelines.

Can FeLV-vaccinated cats live with a positive cat?

Vaccination lowers risk but does not eliminate it. Separation is safest. If mixed-status cats cohabit, negative cats need testing, vaccination and veterinary monitoring with informed acceptance of residual risk.

Key Takeaways

• FeLV vaccination reduces persistent infection and disease but is not 100% effective.
• It is core for kittens and young cats under one year in current US guidance; adult use is exposure-based.
• The primary series is two doses three to four weeks apart beginning at eight weeks or older.
• Give a booster one year after the series; future intervals depend on ongoing risk, product and region.
• Test cats before vaccination and after acquisition, exposure or compatible illness.
• Vaccination does not treat FeLV and does not make routine p27 antigen or proviral DNA tests positive.
• Avoiding infected-cat contact remains the best prevention; vaccination is an additional layer.
• Mild lethargy or soreness can occur; facial swelling, repeated vomiting, collapse or breathing difficulty is an emergency.
• FISS is rare but serious. Document sites and use the 3-2-1 rule for persistent masses.
• Do not use partial doses, owner premedication, unvalidated titers or one universal booster interval.

References

1. Stone AES, et al. 2020 AAHA/AAFP Feline Vaccination Guidelines. J Feline Med Surg. 2020;22:813-830. https://pmc.ncbi.nlm.nih.gov/articles/PMC11135662/
2. Little S, et al. 2020 AAFP Feline Retrovirus Testing and Management Guidelines. J Feline Med Surg. 2020;22:5-30. PMID: 31916872. https://pubmed.ncbi.nlm.nih.gov/31916872/
3. Squires RA, et al. 2024 guidelines for the vaccination of dogs and cats—compiled by the WSAVA Vaccination Guidelines Group. J Small Anim Pract. 2024;65:277-316. https://wsava.org/wp-content/uploads/2024/04/WSAVA-Vaccination-guidelines-2024.pdf
4. Hartmann K, et al. Feline injection-site sarcoma: ABCD guidelines on prevention and management. J Feline Med Surg. 2015;17:606-613. PMID: 26101312. https://pubmed.ncbi.nlm.nih.gov/26101312/
5. Grosenbaugh DA, et al. Efficacy of a nonadjuvanted recombinant FeLV vaccine and two inactivated FeLV vaccines under consistent virulent challenge conditions. Biologicals. 2017;49:76-80. PMID: 28734742. https://pubmed.ncbi.nlm.nih.gov/28734742/
6. Stuke K, et al. Efficacy of an inactivated FeLV vaccine compared to a recombinant FeLV vaccine in minimum-age cats following virulent FeLV challenge. Vaccine. 2014;32:2599-2603. PMID: 24662705. https://pubmed.ncbi.nlm.nih.gov/24662705/
7. Legendre AM, et al. Comparison of the efficacy of three commercial feline leukemia virus vaccines in a natural challenge exposure. J Am Vet Med Assoc. 1991;199:1456-1462. PMID: 1666103. https://pubmed.ncbi.nlm.nih.gov/1666103/
8. Dean RS, et al. The incidence of feline injection site sarcomas in the United Kingdom. BMC Vet Res. 2013;9:17. PMID: 23339769. https://pubmed.ncbi.nlm.nih.gov/23339769/
9. American Animal Hospital Association. 2020 AAHA/AAFP Feline Vaccination Guidelines: Frequently Asked Questions and Vaccination Sites. https://www.aaha.org/resources/2020-aahaaafp-feline-vaccination-guidelines/faqs-5/
10. American Animal Hospital Association. Core Vaccines for Pet Cats: FeLV tables. https://www.aaha.org/resources/2020-aahaaafp-feline-vaccination-guidelines/core-vaccines-for-pet-cats/

Disclaimer: This article is for educational and informational purposes only. It is not a substitute for examination, testing, vaccination or treatment by a licensed veterinarian. Product labels, disease prevalence and legal requirements vary by location and change over time.